<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02405637</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU 7/2013</org_study_id>
    <nct_id>NCT02405637</nct_id>
  </id_info>
  <brief_title>Simulated Amniotic Fluid In Preventing Feeding Intolerance and Necrotizing Enterocolitis VLBW Neonates</brief_title>
  <official_title>Enteral Administration of a Simulated Amniotic Fluid In Preventing Feeding Intolerance And Necrotizing Enterocolitis In Very Low Birth Weight Neonates</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rania Ali El-Farrash</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The human fetus swallows over 200 ml of amniotic fluid per kilogram of weight each day and
      such swallowing is essential for normal small bowel development.Growth factors found in the
      amniotic fluid have been shown to promote proliferation of fetal intestinal cells. As feeding
      intolerance is a common problem among premature neonates, the investigators will study the
      role of enteral administration of simulated amniotic fluid solution in prevention of feeding
      intolerance and NEC in premature neonates.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Very Low Birth Weight (VLBW) neonates.

      Participants will be followed for the duration of hospital stay until discharge or death.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Necrotizing enterocolitis by modified Bell criteria, mortality in percentage, hospital stay in days. The outcome measure will be assessed within 2 months</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Necrotizing Enterocolitis</condition>
  <arm_group>
    <arm_group_label>SAFE group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>simulated amniotic fluid 20cc/kg/day enterally divided according to number of feds (syringe for every fed). This amount provides enteral 4.5Î¼g rhG-CSF / kg/day and enteral 88IU rhEPO / kg/day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>distilled water 2.5 ml/kg every 3 hours enterally</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>simulated amniotic fluid 20cc/kg/day enterally</intervention_name>
    <description>simulated amniotic fluid 20cc/kg/day enterally for a maximum of 7 days.</description>
    <arm_group_label>SAFE group</arm_group_label>
    <other_name>SAFE solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>distilled water</intervention_name>
    <description>distilled water 20 ml/kg/day for maximum of 7 days.</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Premature infants with birth weight 1.5 Kg

        Exclusion Criteria:

          -  Congenital or acquired anomaly of the gastrointestinal tract (i.e., omphalocele,
             tracheoesophageal fistula, intestinal perforation).

          -  Other major congenital anomalies (congenital heart disease, neural tube defect,
             congenital diaphragmatic hernia, trisomy, etc.).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>28 Weeks</minimum_age>
    <maximum_age>36 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rania A El-Farrash, MD</last_name>
    <role>Study Director</role>
    <affiliation>ASU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rania A El-Farrash, MD</last_name>
    <phone>00201222208550</phone>
    <email>raniafarrash@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>1138</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rania A El-Farrash, MD</last_name>
      <phone>00201222208550</phone>
      <email>raniafarrash@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Ahmed S Auda, Msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2015</study_first_submitted>
  <study_first_submitted_qc>March 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2015</study_first_posted>
  <last_update_submitted>March 28, 2015</last_update_submitted>
  <last_update_submitted_qc>March 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Rania Ali El-Farrash</investigator_full_name>
    <investigator_title>Enteral Administration of a Simulated Amniotic Fluid In Preventing Feeding Intolerance And Necrotizing Enterocolitis In Very Low Birth Weight Neonates</investigator_title>
  </responsible_party>
  <keyword>Feeding intolerance</keyword>
  <keyword>Simulated amniotic fluid</keyword>
  <keyword>Necrotizing enterocolitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterocolitis</mesh_term>
    <mesh_term>Enterocolitis, Necrotizing</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

